BMRA biomerica.com: Company Value to Revenue

Public company logo of biomerica.com (BMRA)

Biomerica, Inc. (BMRA) focuses on personalized GI and food intolerance diagnostics in the maturity stage. The EV/Sales valuation multiple demonstrates the market value of the business relative to revenue excluding debt, where the value 1073.73 serves as the baseline indicator. Supplies to clinics in Europe and the US provide geographical reach, while certified home tests create a stable cash flow through pharmacy chains.

Biomerica Inc (BMRA): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

Biomerica Inc - analytical breakdowns and key metrics (BMRA)

- price and consensus price forecast:
- company stock capitalization data:
- money and cash flow information:
Fundamental company valuation:BMRA - Biomerica
Original product of Biomerica, Inc

Rising demand for gastrointestinal diagnostics in the US makes analyzing the efficiency of Biomerica, Inc. (BMRA) through the enterprise value-to-revenue ratio critically important. This EV/Revenue metric, which excludes the impact of debt load, allows investors to filter out market noise and assess the asset's true fundamental value, where inflated figures signal an overbought condition and low values indicate business stagnation.

Direct competitors

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|TRIB: EV/Sales Multiple|ProPhase - Business Value to Revenue|Enterprise Value-to-Revenue Ratio ainos.com|CODX: Business Value to Revenue|Enterprise Value-to-Revenue Ratio HeartSciences (HSCS)|Total Company Value-to-Revenue Ratio Cardio Diagnostics Holdings|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue